Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its Phase II trial. The strategic combination of IL-33 inhibitors with ...

In schoolchildren with asthma, IL-5 is likely a mediator between radon exposure and absolute eosinophil count level. Radon exposure is significantly associated with an increase in interleukin-5 (IL-5) ...

Objective Eosinophils reside in the colonic mucosa and increase significantly during disease. Although a number of studies have suggested that eosinophils contribute to the pathogenesis of GI ...

Starbucks and the union representing thousands of its employees said on Thursday that they were bringing in a mediator in a push to revive contract talks, which had stalled over an impasse on wage ...

Abstract Daptomycin induced acute eosinophilic pneumonia is a rare and potentially life threatening condition characterized by rapid respiratory failure, pulmonary infiltrates and eosinophilia. Risk ...

Benralizumab is an eosinophil-depleting anti–interleukin-5 receptor α monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic esophagitis are unclear.

Numbers of activated eosinophils are higher in patients with active and inactive ulcerative colitis (UC) compared with controls, but higher in the quiescent than in the active phase, indicating that ...

Infiltration of eosinophils across the bronchial vascular epithelium into the airways is promoted by the actions of immunoregulatory cells, cytokines and chemokines, where eosinophil-mediated ...

Hypereosinophilic syndrome (HES) refers to a group of blood disorders caused by high levels of eosinophils. Learn about its symptoms and treatment options.

Eosinophils, but not neutrophils, offer a therapeutic target for preventing the onset and exacerbation of COPD and COPD-related FEV1/FVC decline. An elevated blood eosinophil count (BEC) is a risk ...